Panel Discussion
View Presentation View Presentation
*Howard D. Chazin, FDA/CDER/OND  *Nisha Jain, FDA/CBER  *Jessica Kim, FDA/CBER  *Mary E. Nilsson, Eli Lilly & Company  *George Rochester, FDA, CDER  *Konrad Tomaszewski, Pfizer 

Keywords: